Page last updated: 2024-11-02

phenobarbital and Carcinosarcoma

phenobarbital has been researched along with Carcinosarcoma in 1 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Carcinosarcoma: A malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KATO, R1
FRONTINO, G1
VASSANELLI, P1

Other Studies

1 other study available for phenobarbital and Carcinosarcoma

ArticleYear
Phenobarbital markedly increases liver weight in Walker carcinosarcoma bearing rats.
    Experientia, 1963, Jan-15, Volume: 19

    Topics: Animals; Carcinoma; Carcinoma 256, Walker; Carcinosarcoma; Liver; Phenobarbital; Rats

1963